Details for New Drug Application (NDA): 209499
✉ Email this page to a colleague
The generic ingredient in ICOSAPENT ETHYL is icosapent ethyl. There are twelve drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the icosapent ethyl profile page.
Summary for 209499
Tradename: | ICOSAPENT ETHYL |
Applicant: | Dr Reddys |
Ingredient: | icosapent ethyl |
Patents: | 0 |
Suppliers and Packaging for NDA: 209499
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ICOSAPENT ETHYL | icosapent ethyl | CAPSULE;ORAL | 209499 | ANDA | AvKARE | 42291-032 | 42291-032-12 | 120 CAPSULE in 1 BOTTLE (42291-032-12) |
ICOSAPENT ETHYL | icosapent ethyl | CAPSULE;ORAL | 209499 | ANDA | Dr. Reddy's Laboratories, Inc. | 43598-267 | 43598-267-04 | 120 CAPSULE in 1 BOTTLE (43598-267-04) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 1GM | ||||
Approval Date: | Aug 7, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 500MG | ||||
Approval Date: | Mar 8, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription